Arecor Therapeutics plc (AIM:AREC)
London flag London · Delayed Price · Currency is GBP · Price in GBX
89.70
+1.20 (1.36%)
Sep 25, 2026, 2:45 PM GMT

Arecor Therapeutics Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3330285673111
Market Cap Growth
22.07%9.52%-50.35%-23.94%-34.00%-
Enterprise Value
272925486089
Last Close Price
0.890.810.731.822.404.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
44.2545.77----
PS Ratio
19.5017.7316.8912.2230.5896.15
PB Ratio
5.184.715.195.874.216.00
P/TBV Ratio
5.194.725.228.975.236.01

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
15.9816.7315.5110.4624.9477.27

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.020.040.040.020.01
Net Debt / Equity Ratio
-0.93-0.93-0.57-0.67-0.72-0.97
Net Debt / EBITDA Ratio
1.541.540.610.721.233.07
Net Debt / FCF Ratio
2.452.450.321.071.133.28
Asset Turnover
0.200.200.140.250.110.09
Inventory Turnover
--1.163.49--
Quick Ratio
4.224.222.081.964.198.77
Current Ratio
4.784.782.532.174.699.05
Return on Equity (ROE)
15.79%15.79%-69.41%-63.41%-51.44%-63.85%
Return on Assets (ROA)
-30.05%-30.05%-26.85%-30.88%-30.28%-29.64%
Return on Invested Capital (ROIC)
-484.69%-276.24%-190.40%-227.95%-382.93%-3568.36%
Return on Capital Employed (ROCE)
-62.30%-62.30%-94.70%-89.70%-57.30%-32.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
1.99%2.19%-36.88%-15.30%-12.60%-5.54%
FCF Yield
-7.37%-8.10%-33.65%-10.72%-15.08%-4.96%
Buyback Yield / Dilution
-23.11%-17.94%-9.20%-5.83%-25.63%-41.77%